Back-to-School with Type 1 Diabetes
Starting school is exciting and for families managing T1D, a little planning can make all the difference.
Starting school is exciting and for families managing T1D, a little planning can make all the difference.
We are proud to announce the launch of the new RISE study.
The adventHealth is excited to announce the launch of the SOMMA study. This study aims to better understand how our muscles and mobility function change as we age.
AdventHealth Research Institute’s new review, authored by Drs. Katie Whytock and Bret Goodpaster and published in Circulation Research, highlights how skeletal muscle regulates insulin and glucose...
Dr. Iswanto Sucandy was recently featured on AdventHealth West Florida Division’s “Team Talk” to discuss his groundbreaking textbook.
On July 10, 2025, AdventHealth Director of Neuroscience Clinical Research Anita Fletcher, MD, worked with NKGen Biotech to administer the first dose of troculeucel (SNK01), an investigative natural...
In our latest Clinician’s View, Dr. Seminerio shares her personal passion for improving care for patients with inflammatory bowel disease (IBD) and talks about how AdventHealth’s recently established...
Join the AdventHealth Translational institute as we give a behind the scenes tour of our Translational Research Institute to our friends at Breakthrough T1D.
Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate...
For people with Type 1 diabetes (T1D), low blood sugar episodes—also known as hypoglycemia—can strike fast and hard. The body’s natural defense is to release hormones like glucagon to raise blood...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.